TEVA - Teva Pharmaceutical Industries

TEVA valuation $48.62 billion

Stock Price

56.86
Change: ↓ -0.70 (-1.2161%)
Last Update: 2015-01-30T16:17:49-05:00
Shares Outstanding: 855,000,000
Industry: Drug Manufacturers
Website Investor Relations

Teva Pharmaceutical Industries Ltd. is a pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients.

Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules, sold in more than 100 countries, and with a direct presence in about 60 countries.

Teva's specialty medicine businesses focus on CNS, including pain, respiratory, oncology, and women's health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $20.3 billion in net revenues in 2013.

Stock Price Data

Open: 57.43 Previous Close: 57.56
High: 57.80 Low: 56.84
Bid: 56.82 Ask: 59.46

Bid Size: 200 Ask Size: 200
Raw Bid Size: 2 Raw Ask Size: 2
Trade Volume: 21018 Share Volume: 3261662
Last Trade Date: 2015-01-30 Last Trade Time: 16:05:34-05:00
Vwap: 57.2862594 EPS: 3.21

Fundamental Data

PE ratio: 18.40 PB ratio: 2.057
Beta: 0.640816

52 Week High: 61.90 52 Week Low: 43.22
52 Week High Vwap: 59.3951 52 Week Low Vwap: 43.9524
52 Week High Volume: 15277117 52 Week Low Volume: 913846
52 Week Avg Volume: 4823807

Dividend Data

Dividend: 0.269593 Date: 2014-11-13
Amount: 1.078372 Yield: 1.873
Frequency: Q Paydate: 2014-12-02
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
PFE Pfizer Inc. 31.25
ABBV AbbVie Inc 60.35
MRK Merck & Co. Inc. 60.28
JNJ Johnson & Johnson 100.14
AKRX Akorn Inc. 42.58
BMY Bristol-Myers Squibb Co. 60.27
LLY Eli Lilly & Co. 72.00
MYL Mylan Inc. 53.15
ENDP Endo Health Solutions Inc. 79.61
ZGNX Zogenix Inc. 1.35